Clinical trial NCT03345433: Interactive Group Drumming (IGD) in Hospital Experience of Patients Undergoing Hematopoietic Stem Cell Transplant - A Pilot Study
Official title: Does Interactive Group Drumming (IGD) Improve the Hospital Experience of Patients Undergoing Hematopoietic Stem Cell Transplant? - A Pilot Study
Study type: INTERVENTIONAL
Overall status: COMPLETED
Phase: NA
Conditions: Hematopoietic Cell Transplant
Lead sponsor: Wake Forest University Health Sciences
Sponsor class: OTHER
First posted: 2017-11-17
Enrollment: 35
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: SINGLE_GROUP
Intervention model description: interactive group drumming sessions
Primary purpose: SUPPORTIVE_CARE

Brief summary: The purpose of this research is to determine if it is possible to perform group drumming as an intervention during HCT, to begin to understand how interactive group drumming during HCT treatment affects patients' well-being (good and bad) during the treatment course and in the first four weeks after completion of the drumming sessions.

Detailed description: The purpose of this research is to determine if it is possible to perform group drumming as an intervention during HCT, to begin to understand how interactive group drumming during HCT treatment affects patients' well-being (good and bad) during the treatment course and in the first four weeks after completion of the drumming sessions.

Eligibility criteria: Inclusion Criteria:

* People who are at least 18 years old and are scheduled for HCT
* Individuals must be able to understand and willing to sign a written informed consent form

Exclusion Criteria:

* People who are too ill to participate, i.e., while they are in contact isolation or have low platelets (less than 20,000/mcl) will not participate until their condition has improved.
* Patients receiving outpatient HCT except patients with multiple myeloma. Patients with multiple myeloma may participate in the study even though they tend to spend nights away from the hospital.

Primary outcomes:
measure: Rate of participation
timeFrame: Up to 1 week after hematopoietic cell transplant (HCT)
measure: Rate of completion
timeFrame: Up to 1 week after HCT
Secondary outcomes:
measure: Gather patient-reported data to suggest how participants respond to interactive group drumming (IGD)
timeFrame: Baseline up to 4 weeks after completion of IGD
measure: Determine optimum length of session
timeFrame: Up to 4 weeks after completion of IGD
measure: Gather patient-reported information to study whether the effect of interactive group drumming (IGD) on targeted variables is more pronounced in successive sessions
timeFrame: Baseline up to 4 weeks after completion of IGD
measure: Effect of support care provider (SCP) presence for each participant and among participants
timeFrame: Up to 4 weeks after completion of IGD
measure: Change in physiological response to interactive group drumming (IGD)
timeFrame: Baseline up to 1 week after HCT
measure: Gather patient-reported information to suggest the optimal number of interactive group drumming (IGD) sessions
timeFrame: Baseline up to 4 weeks after completion of IGD
Other outcomes:
Locations:
city: Winston-Salem
country: United States
facility: Wake Forest University Health Sciences
state: North Carolina
Study officials:
affiliation: Wake Forest University Health Sciences
name: Richard McQuellon, PhD
role: STUDY_CHAIR
References: